Association between dyslipidemia and antihypertensive and antidiabetic treatments in a China multicenter study
Autor: | Chao‐Ying Miao, Xiao‐Fei Ye, Wei Zhang, Li‐Nong Ji, Ji‐Guang Wang, for the ATTEND investigators |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: | |
Zdroj: | The Journal of Clinical Hypertension, Vol 23, Iss 7, Pp 1399-1404 (2021) |
Druh dokumentu: | article |
ISSN: | 1751-7176 1524-6175 |
DOI: | 10.1111/jch.14264 |
Popis: | Abstract Dyslipidemia is an emerging disease in China, especially in the presence of hypertension and diabetes mellitus. We investigated the association of dyslipidemia with the use of antihypertensive and antidiabetic agents. The study participants (n = 2423) were hypertensive and diabetic patients enrolled in a China nationwide registry. Serum mean ± (SD, except for serum triglycerides, median [interquatile range]) concentrations were 1.38 (0.97‐2.02) mmol/L, 4.85 ± 1.12 mmol/L, 1.30 ± 0.36 mmol/L, and 2.89 ± 0.92 mmol/L for triglycerides and total, high‐density lipoprotein (HDL), and low‐density lipoprotein (LDL) cholesterol, respectively. The prevalence of dyslipidemia was 18.9%, 13.5%, 16.6%, and 37.7% for hypertriglyceridemia (serum triglycerides ≥2.3 mmol/L), hypercholesterolemia (total cholesterol ≥6.2 mmol/L or LDL cholesterol ≥4.1 mmol/L), low HDL cholesterol (HDL cholesterol |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |